Japanese
A-001
Prospective observational Study to explore the efficacy of Eribulin as 1st-line or 2nd-line chemotherapy in patients with HER2-negative hormone-resistant inoperable or recurrent metastatic breast cancer
A-002
A Clinical Study to Explore Prediction of Response to Abemaciclib and Predictors of Intestinal Toxicity in ER-positive Metastatic Breast Cancer
A-004
Multicenter observational study of chemotherapy-induced peripheral neuropathy prevention
B-001
Phase II study to assess efficacy, safety & immunological biomarker of anti PD-L1 antibody + anti CTLA-4 antibody in combination with hormone therapy in patients with hormone receptor positive HER2-negative recurrent or metastatic breast cancer
B-002
Phase Ib/II study to assess efficacy, safety & immunological biomarker of anti PD-1 antibody with radiation therapy in patients with HER-2-negative metastatic breast cancer
B-003
A Phase III Randomized, Double-Blind, Neoadjuvant Study of Hormonal Therapy plus Palbociclib versus Hormonal Therapy plus Placebo in Women with Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer
Kyoto University Hospital
Kyoto University Hospital Breast Surgery Department
Kyoto University Hospital Department of Radiation Oncology and Image applied Therapy
Kyoto University Hospital Unit of Outpatient Oncology
